(Q40020547)

English

Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases

scientific article published on 23 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Pavani Srimatkandada

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Regina Loomis

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Rocco Carbone

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Srinivasan Srimatkandada

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Jill Lacy

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

23 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

80

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

407-418

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Signal transduction from the Epstein-Barr virus LMP-1 transforming protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Bortezomib: proteasome inhibition as an effective anticancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Critical upstream signals of cytochrome C release induced by a novel Bcl-2 inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Signaling networks that link cell proliferation and cell fate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

c-Myc functionally cooperates with Bax to induce apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Quantitative proteomic analysis of myc-induced apoptosis: a direct role for Myc induction of the mitochondrial chloride ion channel, mtCLIC/CLIC4

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Apoptosis-based therapies for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2008.01044.X

21 January 2018

Identifiers

10.1111/J.1600-0609.2008.01044.X

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40020547&oldid=1882698348"